Folger Hill Asset Management’s Medicines Co MDCO Stock Holding History

Folger Hill Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-212,930	Closed	-$7.23M	–	396
2016 Q4	$7.23M	Sell	212,930 -208,620	-49%	-$7.4M	0.65%	58
2016 Q3	$15.9M	Sell	421,550 -214,180	-34%	-$8.07M	0.95%	23
2016 Q2	$21.4M	Sell	635,730 -66,684	-9%	-$2.35M	1.67%	7
2016 Q1	$22.3M	Buy	702,414 +5,961	+0.9%	+$195K	1.25%	13
2015 Q4	$26M	Buy	+696,453	New	+$26.3M	1.57%	15

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Folger Hill Asset Management's MDCO Position: Q1 2017 in Review

Folger Hill Asset Management sold out of Medicines Co (MDCO) in Q1 2017, closing a stake of 212,930 shares — an estimated $7.23M sold.

Folger Hill Asset Management first reported a position in MDCO in Q4 2015 and held it in 5 quarters. The position peaked at $26M in Q4 2015. 220 funds tracked by Wall St. Rank hold MDCO as of Q1 2017.

Folger Hill Asset Management reported no remaining Medicines Co position as of Q1 2017 after selling out during the quarter.
Folger Hill Asset Management sold 212,930 Medicines Co shares in Q1 2017, an estimated $7.23M.
Folger Hill Asset Management first reported a position in Medicines Co in Q4 2015 and held it in 5 quarters.
Folger Hill Asset Management's Medicines Co position peaked at $26M in Q4 2015.
220 funds tracked by Wall St. Rank held Medicines Co as of Q1 2017.

Based on Folger Hill Asset Management's 13F filing for Q1 2017, filed 15 May 2017.